Like, OK, I took my supplement, and now Im going to go to the gym
aeruginosa to form biofilms and produce virulence factors, thus attenuating infections
Yes, based on the available research
Notably, patients with MASH or cirrhosis showed greater relative benefit from combination therapy compared to those without these conditions, suggesting that patients with more advanced liver disease might be prime candidates for this therapeutic approach
In accordance with the target trial emulation framework, we first specified the protocol of a hypothetical randomized controlled trial (RCT) comparing the effects of initiating a GLP-1RA versus an SGLT2 inhibitor on the outcomes of AF/Aflutter and stroke among patients with T2D who have been receiving stable dose of levothyroxine
COAs are documentation records and do not change the laboratory research-only status of any product